產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C2orf49抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C2orf49抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C2orf49
Cat. Number:
Anti-C2orf49抗體KL-15150R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C2orf49 (chromosome 2 open reading frame 49), also known as asw, Ashwin, MGC5509 or FLJ45759, is a 232 amino acid member of the ashwin family and is encoded by a gene located on human chromosome Anti-C2orf49抗體2q12.2. The second largest human chromosome, chromosome 2 consists of 237 million bases encoding over 1,400 genes and making up approximately 8% of the human genome. A number of genetic diseases are linked to genes on chromosome 2. Harlequin icthyosis, a rare and morbid skin deformity, is associated with mutations in the ABCA12 gene. The lipid metabolic disorder sitosterolemia is associated with ABCG5 and ABCG8. An extremely rare recessive genetic disorder, Alstr鰉 syndrome is due to mutations in the ALMS1 gene. Interestingly, chromosome 2 contains what appears to be a vestigial second centromere and vestigial telomeres which gives credence to the hypothesis that human chromosome 2 is the result of an ancient fusion of two ancestral chromosomes seen in modern form today in apes.
Also known as:
Ashwin; asw; Chromosome 2Anti-C2orf49抗體 open reading frame 49; FLJ45759; MGC5509; ASHWN_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C2orf49.
●
Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C2orf49抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-C2orf49抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-C2orf49抗體must be determined by the end user.
kl047Hu02 肝細(xì)胞生長(zhǎng)因子(HGF)多克隆抗體 Polyclonal Antibody to Heklocyte Growth Factor (HGF)
kl066Hu02 白介素1受體Ⅰ(IL1R1)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl066Hu03 白介素1受體Ⅰ(IL1R1)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl066Ra03 白介素1受體Ⅰ(IL1R1)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl106Hu02 神經(jīng)營(yíng)養(yǎng)因子3(NT3)多克隆抗體 Polyclonal Antibody to Neurotrophin 3 (NT3)
kl119Hu02 CD40配體(CD40L)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 40 Ligand (CD40L)
kl141Hu03 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl235Ra02 補(bǔ)體1抑制因子(C1INH)多克隆抗體 Polyclonal Antibody to Complement 1 Inhibitor (C1INH)
kl262Hu03 轉(zhuǎn)鐵蛋白受體2(TFR2)多克隆抗體 Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl449Hu02 胱天蛋白酶7(CASP7)多克隆抗體 Polyclonal Antibody to Caskle 7 (CASP7)
kl537Hu02 神經(jīng)元特異性烯醇化酶(NSE)多克隆抗體 Polyclonal Antibody to Enolase, Neuron Specific (NSE)
kl537Mu02 神經(jīng)元特異性烯醇化酶(NSE)多克隆抗體 Polyclonal Antibody to Enolase, Neuron Specific (NSE)
kl547Mu02 血管細(xì)胞粘附分子1(VCAM1)多克隆抗體 Polyclonal Antibody to Vascular Cell Adhesion Molecule 1 (VCAM1)
kl556Ra02 角蛋白7(KRT7)多克隆抗體 Polyclonal Antibody to Keratin 7 (KRT7)
kl557Mu01 甲狀腺過氧化物酶(TPO)多克隆抗體 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl561Hu03 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Mu02 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
